<http://schema.org/headline>
"AstraZeneca claims PhIII sweep for OIC drug as CV concerns linger"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fiercebiotech.com/story/astrazeneca-claims-phiii-sweep-oic-drug-cv-concerns-linger/2013-02-26>